Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126121251 | 12612125 | 1 | I | 20160419 | 20160722 | 20160801 | 20160801 | EXP | US-GLAXOSMITHKLINE-US2016108407 | GLAXOSMITHKLINE | 84.00 | YR | F | Y | 0.00000 | 20160801 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126121251 | 12612125 | 1 | PS | VOLTAREN | DICLOFENAC SODIUM | 1 | UNK | N | UNK | 22122 | GEL | ||||||||
| 126121251 | 12612125 | 2 | SS | VOLTAREN | DICLOFENAC SODIUM | 1 | 2 G, TID | N | W5751 | 22122 | 2 | G | GEL | TID | |||||
| 126121251 | 12612125 | 3 | SS | SUNBLOCK | OCTINOXATETITANIUM DIOXIDE | 1 | UNK | U | UNK | 0 | |||||||||
| 126121251 | 12612125 | 4 | C | MINERAL ICE PAIN RELIEVING | MENTHOL | 1 | UNK | U | UNK | 0 | GEL |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126121251 | 12612125 | 1 | Arthritis |
| 126121251 | 12612125 | 3 | Product used for unknown indication |
| 126121251 | 12612125 | 4 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126121251 | 12612125 | Application site acne | |
| 126121251 | 12612125 | Application site discomfort | |
| 126121251 | 12612125 | Application site erythema | |
| 126121251 | 12612125 | Application site pain | |
| 126121251 | 12612125 | Application site pruritus | |
| 126121251 | 12612125 | Application site rash | |
| 126121251 | 12612125 | Application site reaction | |
| 126121251 | 12612125 | Chest pain | |
| 126121251 | 12612125 | Dermatitis contact | |
| 126121251 | 12612125 | Hyperhidrosis | |
| 126121251 | 12612125 | Hypertension | |
| 126121251 | 12612125 | Incorrect dosage administered | |
| 126121251 | 12612125 | Miliaria | |
| 126121251 | 12612125 | Vasodilatation | |
| 126121251 | 12612125 | Vein discolouration | |
| 126121251 | 12612125 | Vulvovaginal pruritus | |
| 126121251 | 12612125 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126121251 | 12612125 | 2 | 20160419 | 20160521 | 0 |